搜索结果：Critical care medicine

Domain-specific foundation models for healthcare have expanded rapidly in recent years, yet foundation models for critical care time series remain relatively underexplored due to the limited size and availability of datasets. In this work, we introduce an early-stage pre-trained foundation model for critical care time-series based on the Bi-Axial Transformer (BAT), trained on pooled electronic health record datasets. We demonstrate effective transfer learning by fine-tuning the model on a dataset distinct from the training sources for mortality prediction, where it outperforms supervised baselines, particularly for small datasets ($<5,000$). These contributions highlight the potential of self-supervised foundation models for critical care times series to support generalizable and robust clinical applications in resource-limited settings.

End-stage renal disease patients face a complicated sociomedical situation and rely on various forms of infrastructure for life-sustaining treatment. Disruption of these infrastructures during disasters poses a major threat to their lives. To improve patient access to dialysis treatment, there is a need to assess the potential threat to critical care facilities from hazardous events. In this study, we propose optimization models to solve critical care system resilience problems including patient and medical resource allocation. We use human mobility data in the context of Harris County (Texas) to assess patient access to critical care facilities, dialysis centers in this study, under the simulated hazard impacts, and we propose models for patient re-allocation and temporary medical facility placement to improve critical care system resilience in an equitable manner. The results show (1) the capability of the optimization model in efficient patient re-allocation to alleviate disrupted access to dialysis facilities; (2) the importance of large facilities in maintaining the functioning of the system. The critical care system, particularly the network of dialysis centers, is heavily re

The medical ecosystem consists of the training of new clinicians and researchers, the practice of clinical medicine, and areas of adjacent research. There are many aspects of these domains that could benefit from the application of task automation and programmatic assistance. Machine learning and artificial intelligence techniques, including large language models (LLMs), have been promised to deliver on healthcare innovation, improving care speed and accuracy, and reducing the burden on staff for manual interventions. However, LLMs have no understanding of objective truth that is based in reality. They also represent real risks to the disclosure of protected information when used by clinicians and researchers. The use of AI in medicine in general, and the deployment of LLMs in particular, therefore requires careful consideration and thoughtful application to reap the benefits of these technologies while avoiding the dangers in each context.

In the much-celebrated book Deep Medicine, Eric Topol argues that the development of artificial intelligence for health care will lead to a dramatic shift in the culture and practice of medicine. In the next several decades, he suggests, AI will become sophisticated enough that many of the everyday tasks of physicians could be delegated to it. Topol is perhaps the most articulate advocate of the benefits of AI in medicine, but he is hardly alone in spruiking its potential to allow physicians to dedicate more of their time and attention to providing empathetic care for their patients in the future. Unfortunately, several factors suggest a radically different picture for the future of health care. Far from facilitating a return to a time of closer doctor-patient relationships, the use of medical AI seems likely to further erode therapeutic relationships and threaten professional and patient satisfaction.

In critical care settings such as the Intensive Care Unit, clinicians face the complex challenge of balancing conflicting objectives, primarily maximizing patient survival while minimizing resource utilization (e.g., length of stay). Single-objective Reinforcement Learning approaches typically address this by optimizing a fixed scalarized reward function, resulting in rigid policies that fail to adapt to varying clinical priorities. Multi-objective Reinforcement Learning (MORL) offers a solution by learning a set of optimal policies along the Pareto Frontier, allowing for dynamic preference selection at test time. However, applying MORL in healthcare necessitates strict offline learning from historical data. In this paper, we benchmark three offline MORL algorithms, Conditioned Conservative Pareto Q-Learning (CPQL), Adaptive CPQL, and a modified Pareto Efficient Decision Agent (PEDA) Decision Transformer (PEDA DT), against three scalarized single-objective baselines (BC, CQL, and DDQN) on the MIMIC-IV dataset. Using Off-Policy Evaluation (OPE) metrics, we demonstrate that PEDA DT algorithm offers superior flexibility compared to static scalarized baselines. Notably, our results ext

Interpretability plays a vital role in aligning and deploying deep learning models in critical care, especially in constantly evolving conditions that influence patient survival. However, common interpretability algorithms face unique challenges when applied to dynamic prediction tasks, where patient trajectories evolve over time. Gradient, Occlusion, and Permutation-based methods often struggle with time-varying target dependency and temporal smoothness. This work systematically analyzes these failure modes and supports learnable mask-based interpretability frameworks as alternatives, which can incorporate temporal continuity and label consistency constraints to learn feature importance over time. Here, we propose that learnable mask-based approaches for dynamic timeseries prediction problems provide more reliable and consistent interpretations for applications in critical care and similar domains.

Notable progress has been made in generalist medical large language models across various healthcare areas. However, large-scale modeling of in-hospital time series data - such as vital signs, lab results, and treatments in critical care - remains underexplored. Existing datasets are relatively small, but combining them can enhance patient diversity and improve model robustness. To effectively utilize these combined datasets for large-scale modeling, it is essential to address the distribution shifts caused by varying treatment policies, necessitating the harmonization of treatment variables across the different datasets. This work aims to establish a foundation for training large-scale multi-variate time series models on critical care data and to provide a benchmark for machine learning models in transfer learning across hospitals to study and address distribution shift challenges. We introduce a harmonized dataset for sequence modeling and transfer learning research, representing the first large-scale collection to include core treatment variables. Future plans involve expanding this dataset to support further advancements in transfer learning and the development of scalable, gen

Relationship-centred care (RCC) recognises that healthcare quality depends not only on outcomes, but on how voice, responsibility, and emotional labour are negotiated among patients, caregivers, and providers. As AI systems enter sensitive care contexts, they introduce a new participant into these negotiations. Drawing on empirical work in Advance Care Planning (ACP) and peer support, we argue that AI's primary impact in high-subjectivity domains is not optimisation but redistribution: it reorganises who speaks, who decides, and who bears moral responsibility. Across both settings, participants were less concerned with technical accuracy than with relational consequences: whether AI would appropriately represent their decision, reduce burden, or blur accountability, scaffold connection, or subtly displace it. We identify three relational dimensions: authority, temporality, and visibility, through which AI reshapes care relationships, and propose design provocations centred on relational legibility, bounded agency, responsibility traceability, and non-substitutive scaffolding.

The CARE Workshop on Robotics and AI in Medicine, held on December 1, 2025 in Indianapolis, convened leading researchers, clinicians, industry innovators, and federal stakeholders to shape a national vision for advancing robotics and artificial intelligence in healthcare. The event highlighted the accelerating need for coordinated research efforts that bridge engineering innovation with real clinical priorities, emphasizing safety, reliability, and translational readiness with an emphasis on the use of robotics and AI to achieve this readiness goal. Across keynotes, panels, and breakout sessions, participants underscored critical gaps in data availability, standardized evaluation methods, regulatory pathways, and workforce training that hinder the deployment of intelligent robotic systems in surgical, diagnostic, rehabilitative, and assistive contexts. Discussions emphasized the transformative potential of AI enabled robotics to improve precision, reduce provider burden, expand access to specialized care, and enhance patient outcomes particularly in undeserved regions and high risk procedural domains. Special attention was given to austere settings, disaster and relief and military

Fluid administration, also called fluid resuscitation, is a medical treatment to restore the lost blood volume and optimize cardiac functions in critical care scenarios such as burn, hemorrhage, and septic shock. Automated fluid administration systems (AFAS), a potential means to improve the treatment, employ computational control algorithms to automatically adjust optimal fluid infusion dosages by targeting physiological variables (e.g., blood volume or blood pressure). Most of the existing AFAS control algorithms are model-based approaches, and their performance is highly dependent on the model accuracy, making them less desirable in real-world care of critically ill patients due to complexity and variability of modeling patients physiological states. This work presents a novel model-free reinforcement learning (RL) approach for the control of fluid infusion dosages in AFAS systems. The proposed RL agent learns to adjust the blood volume to a desired value by choosing the optimal infusion dosages using a Q-learning algorithm. The RL agent learns the optimal actions by interacting with the environment (without having the knowledge of system dynamics). The proposed methodology (i)

What does Artificial Intelligence (AI) have to contribute to health care? And what should we be looking out for if we are worried about its risks? In this paper we offer a survey, and initial evaluation, of hopes and fears about the applications of artificial intelligence in medicine. AI clearly has enormous potential as a research tool, in genomics and public health especially, as well as a diagnostic aid. It's also highly likely to impact on the organisational and business practices of healthcare systems in ways that are perhaps under-appreciated. Enthusiasts for AI have held out the prospect that it will free physicians up to spend more time attending to what really matters to them and their patients. We will argue that this claim depends upon implausible assumptions about the institutional and economic imperatives operating in contemporary healthcare settings. We will also highlight important concerns about privacy, surveillance, and bias in big data, as well as the risks of over trust in machines, the challenges of transparency, the deskilling of healthcare practitioners, the way AI reframes healthcare, and the implications of AI for the distribution of power in healthcare ins

Progress of machine learning in critical care has been difficult to track, in part due to absence of public benchmarks. Other fields of research (such as computer vision and natural language processing) have established various competitions and public benchmarks. Recent availability of large clinical datasets has enabled the possibility of establishing public benchmarks. Taking advantage of this opportunity, we propose a public benchmark suite to address four areas of critical care, namely mortality prediction, estimation of length of stay, patient phenotyping and risk of decompensation. We define each task and compare the performance of both clinical models as well as baseline and deep learning models using eICU critical care dataset of around 73,000 patients. This is the first public benchmark on a multi-centre critical care dataset, comparing the performance of clinical gold standard with our predictive model. We also investigate the impact of numerical variables as well as handling of categorical variables on each of the defined tasks. The source code, detailing our methods and experiments is publicly available such that anyone can replicate our results and build upon our work.

The integration of artificial intelligence [AI] into clinical trials has revolutionized the process of drug development and personalized medicine. Among these advancements, deep learning and predictive modelling have emerged as transformative tools for optimizing clinical trial design, patient recruitment, and real-time monitoring. This study explores the application of deep learning techniques, such as convolutional neural networks [CNNs] and transformerbased models, to stratify patients, forecast adverse events, and personalize treatment plans. Furthermore, predictive modelling approaches, including survival analysis and time-series forecasting, are employed to predict trial outcomes, enhancing efficiency and reducing trial failure rates. To address challenges in analysing unstructured clinical data, such as patient notes and trial protocols, natural language processing [NLP] techniques are utilized for extracting actionable insights. A custom dataset comprising structured patient demographics, genomic data, and unstructured text is curated for training and validating these models. Key metrics, including precision, recall, and F1 scores, are used to evaluate model performance, wh

Granting LLMs direct control over costly, irreversible scientific experiments leads to unsafe exploration and unstable performance, but discarding LLM creativity entirely sacrifices significant optimization potential. We introduce CARE (Controlling LLM-Generated Policies through Auditable Review of Evidence in Scientific Experimentation), an auditable controller for high-throughput experimentation (HTE) optimization that keeps a non-LLM incumbent optimizer as the default action path while using LLMs to revise challenger ranking policies. Before each outcome is revealed, a public-evidence intervention gate compares the challenger with the incumbent. It authorizes the challenger's selection only when the evidence available before selection supports the change, with the decision recorded in the audit log. CARE outperforms all other evaluated methods on Minerva/Olympus and ChemLex benchmarks, with final-best improving from 80.0 to 88.5 on Minerva/Olympus and from 83.9 to 92.1 on ChemLex, relative to the public incumbent. Our experiments indicate that LLM self-evolution is more reliable when it expands the proposal space under an auditable controller, rather than directly choosing exper

As machine learning (ML) continues its rapid expansion, the environmental cost of model training and inference has become a critical societal concern. Existing benchmarks overwhelmingly focus on standard performance metrics such as accuracy, BLEU, or mAP, while largely ignoring energy consumption and carbon emissions. This single-objective evaluation paradigm is increasingly misaligned with the practical requirements of large-scale deployment, particularly in energy-constrained environments such as mobile devices, developing regions, and climate-aware enterprises. In this paper, we propose AI-CARE, an evaluation tool for reporting energy consumption, and carbon emissions of ML models. In addition, we introduce the carbon-performance tradeoff curve, an interpretable tool that visualizes the Pareto frontier between performance and carbon cost. We demonstrate, through theoretical analysis and empirical validation on representative ML workloads, that carbon-aware benchmarking changes the relative ranking of models and encourages architectures that are simultaneously accurate and environmentally responsible. Our proposal aims to shift the research community toward transparent, multi-obj

We propose the Multimodal Clinical Benchmark for Emergency Care (MC-BEC), a comprehensive benchmark for evaluating foundation models in Emergency Medicine using a dataset of 100K+ continuously monitored Emergency Department visits from 2020-2022. MC-BEC focuses on clinically relevant prediction tasks at timescales from minutes to days, including predicting patient decompensation, disposition, and emergency department (ED) revisit, and includes a standardized evaluation framework with train-test splits and evaluation metrics. The multimodal dataset includes a wide range of detailed clinical data, including triage information, prior diagnoses and medications, continuously measured vital signs, electrocardiogram and photoplethysmograph waveforms, orders placed and medications administered throughout the visit, free-text reports of imaging studies, and information on ED diagnosis, disposition, and subsequent revisits. We provide performance baselines for each prediction task to enable the evaluation of multimodal, multitask models. We believe that MC-BEC will encourage researchers to develop more effective, generalizable, and accessible foundation models for multimodal clinical data.

Model Medicine is the science of understanding, diagnosing, treating, and preventing disorders in AI models, grounded in the principle that AI models -- like biological organisms -- have internal structures, dynamic processes, heritable traits, observable symptoms, classifiable conditions, and treatable states. This paper introduces Model Medicine as a research program, bridging the gap between current AI interpretability research (anatomical observation) and the systematic clinical practice that complex AI systems increasingly require. We present five contributions: (1) a discipline taxonomy organizing 15 subdisciplines across four divisions -- Basic Model Sciences, Clinical Model Sciences, Model Public Health, and Model Architectural Medicine; (2) the Four Shell Model (v3.3), a behavioral genetics framework empirically grounded in 720 agents and 24,923 decisions from the Agora-12 program, explaining how model behavior emerges from Core--Shell interaction; (3) Neural MRI (Model Resonance Imaging), a working open-source diagnostic tool mapping five medical neuroimaging modalities to AI interpretability techniques, validated through four clinical cases demonstrating imaging, compari

We find ourselves on the ever-shifting cusp of an AI revolution -- with potentially metamorphic implications for the future practice of healthcare. For many, such innovations cannot come quickly enough; as healthcare systems worldwide struggle to keep up with the ever-changing needs of our populations. And yet, the potential of AI tools and systems to shape healthcare is as often approached with great trepidation as celebrated by health professionals and patients alike. These fears alight not only in the form of privacy and security concerns but for the potential of AI tools to reduce patients to datapoints and professionals to aggregators -- to make healthcare, in short, less caring. This infixated concern, we - as designers, developers and researchers of AI systems - believe it essential we tackle head on; if we are not only to overcome the AI implementation gap, but realise the potential of AI systems to truly augment human-centred practices of care. This, we argue we might yet achieve by realising newly-accessible practices of AI healthcare innovation, engaging providers, recipients and affected communities of care in the inclusive design of AI tools we may yet enthusiastically